Global Intramuscular Drug Delivery Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Intramuscular Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intramuscular Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Infectious Disease accounting for % of the Intramuscular Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drug Molecule segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Intramuscular Drug Delivery include Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, and Inovio Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intramuscular Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Intramuscular Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Intramuscular Drug Delivery, with revenue, gross margin and global market share of Intramuscular Drug Delivery from 2019 to 2022.
Chapter 3, the Intramuscular Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Intramuscular Drug Delivery market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Intramuscular Drug Delivery research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intramuscular Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Infectious Disease accounting for % of the Intramuscular Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drug Molecule segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Intramuscular Drug Delivery include Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, and Inovio Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intramuscular Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Drug Molecule
- Delivery Devices
- Infectious Disease
- Oncology
- Autoimmune Diseases
- Antares Pharma
- Eli Lily
- Galaxo
- HMD pharmaceuticals
- Inovio Pharmaceuticals
- Merck
- Novartis
- Pacira Pharmaceuticals
- Pfizer
- Pharmajet
- Teva Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Intramuscular Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Intramuscular Drug Delivery, with revenue, gross margin and global market share of Intramuscular Drug Delivery from 2019 to 2022.
Chapter 3, the Intramuscular Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Intramuscular Drug Delivery market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Intramuscular Drug Delivery research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Intramuscular Drug Delivery
1.2 Classification of Intramuscular Drug Delivery by Type
1.2.1 Overview: Global Intramuscular Drug Delivery Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Intramuscular Drug Delivery Revenue Market Share by Type in 2021
1.2.3 Drug Molecule
1.2.4 Delivery Devices
1.3 Global Intramuscular Drug Delivery Market by Application
1.3.1 Overview: Global Intramuscular Drug Delivery Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Global Intramuscular Drug Delivery Market Size & Forecast
1.5 Global Intramuscular Drug Delivery Market Size and Forecast by Region
1.5.1 Global Intramuscular Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Intramuscular Drug Delivery Market Size by Region, (2017-2022)
1.5.3 North America Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.4 Europe Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.6 South America Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Intramuscular Drug Delivery Market Drivers
1.6.2 Intramuscular Drug Delivery Market Restraints
1.6.3 Intramuscular Drug Delivery Trends Analysis
2 COMPANY PROFILES
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business
2.1.3 Antares Pharma Intramuscular Drug Delivery Product and Solutions
2.1.4 Antares Pharma Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Antares Pharma Recent Developments and Future Plans
2.2 Eli Lily
2.2.1 Eli Lily Details
2.2.2 Eli Lily Major Business
2.2.3 Eli Lily Intramuscular Drug Delivery Product and Solutions
2.2.4 Eli Lily Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Eli Lily Recent Developments and Future Plans
2.3 Galaxo
2.3.1 Galaxo Details
2.3.2 Galaxo Major Business
2.3.3 Galaxo Intramuscular Drug Delivery Product and Solutions
2.3.4 Galaxo Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Galaxo Recent Developments and Future Plans
2.4 HMD pharmaceuticals
2.4.1 HMD pharmaceuticals Details
2.4.2 HMD pharmaceuticals Major Business
2.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Product and Solutions
2.4.4 HMD pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 HMD pharmaceuticals Recent Developments and Future Plans
2.5 Inovio Pharmaceuticals
2.5.1 Inovio Pharmaceuticals Details
2.5.2 Inovio Pharmaceuticals Major Business
2.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
2.5.4 Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Inovio Pharmaceuticals Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Intramuscular Drug Delivery Product and Solutions
2.6.4 Merck Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Merck Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Intramuscular Drug Delivery Product and Solutions
2.7.4 Novartis Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Pacira Pharmaceuticals
2.8.1 Pacira Pharmaceuticals Details
2.8.2 Pacira Pharmaceuticals Major Business
2.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
2.8.4 Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pacira Pharmaceuticals Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Intramuscular Drug Delivery Product and Solutions
2.9.4 Pfizer Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Pharmajet
2.10.1 Pharmajet Details
2.10.2 Pharmajet Major Business
2.10.3 Pharmajet Intramuscular Drug Delivery Product and Solutions
2.10.4 Pharmajet Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pharmajet Recent Developments and Future Plans
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business
2.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Product and Solutions
2.11.4 Teva Pharmaceutical Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Teva Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Intramuscular Drug Delivery Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Intramuscular Drug Delivery Players Market Share in 2021
3.2.2 Top 10 Intramuscular Drug Delivery Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Intramuscular Drug Delivery Players Head Office, Products and Services Provided
3.4 Intramuscular Drug Delivery Mergers & Acquisitions
3.5 Intramuscular Drug Delivery New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Intramuscular Drug Delivery Revenue and Market Share by Type (2017-2022)
4.2 Global Intramuscular Drug Delivery Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Intramuscular Drug Delivery Revenue Market Share by Application (2017-2022)
5.2 Global Intramuscular Drug Delivery Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Intramuscular Drug Delivery Revenue by Type (2017-2028)
6.2 North America Intramuscular Drug Delivery Revenue by Application (2017-2028)
6.3 North America Intramuscular Drug Delivery Market Size by Country
6.3.1 North America Intramuscular Drug Delivery Revenue by Country (2017-2028)
6.3.2 United States Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
6.3.3 Canada Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
6.3.4 Mexico Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Intramuscular Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Intramuscular Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Intramuscular Drug Delivery Market Size by Country
7.3.1 Europe Intramuscular Drug Delivery Revenue by Country (2017-2028)
7.3.2 Germany Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.3 France Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.5 Russia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.6 Italy Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Intramuscular Drug Delivery Revenue by Type (2017-2028)
8.2 Asia-Pacific Intramuscular Drug Delivery Revenue by Application (2017-2028)
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Intramuscular Drug Delivery Revenue by Region (2017-2028)
8.3.2 China Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.3 Japan Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.4 South Korea Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.5 India Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.7 Australia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Intramuscular Drug Delivery Revenue by Type (2017-2028)
9.2 South America Intramuscular Drug Delivery Revenue by Application (2017-2028)
9.3 South America Intramuscular Drug Delivery Market Size by Country
9.3.1 South America Intramuscular Drug Delivery Revenue by Country (2017-2028)
9.3.2 Brazil Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
9.3.3 Argentina Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Intramuscular Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East & Africa Intramuscular Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Intramuscular Drug Delivery Revenue by Country (2017-2028)
10.3.2 Turkey Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
10.3.4 UAE Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Intramuscular Drug Delivery
1.2 Classification of Intramuscular Drug Delivery by Type
1.2.1 Overview: Global Intramuscular Drug Delivery Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Intramuscular Drug Delivery Revenue Market Share by Type in 2021
1.2.3 Drug Molecule
1.2.4 Delivery Devices
1.3 Global Intramuscular Drug Delivery Market by Application
1.3.1 Overview: Global Intramuscular Drug Delivery Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Global Intramuscular Drug Delivery Market Size & Forecast
1.5 Global Intramuscular Drug Delivery Market Size and Forecast by Region
1.5.1 Global Intramuscular Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Intramuscular Drug Delivery Market Size by Region, (2017-2022)
1.5.3 North America Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.4 Europe Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.6 South America Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Intramuscular Drug Delivery Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Intramuscular Drug Delivery Market Drivers
1.6.2 Intramuscular Drug Delivery Market Restraints
1.6.3 Intramuscular Drug Delivery Trends Analysis
2 COMPANY PROFILES
2.1 Antares Pharma
2.1.1 Antares Pharma Details
2.1.2 Antares Pharma Major Business
2.1.3 Antares Pharma Intramuscular Drug Delivery Product and Solutions
2.1.4 Antares Pharma Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Antares Pharma Recent Developments and Future Plans
2.2 Eli Lily
2.2.1 Eli Lily Details
2.2.2 Eli Lily Major Business
2.2.3 Eli Lily Intramuscular Drug Delivery Product and Solutions
2.2.4 Eli Lily Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Eli Lily Recent Developments and Future Plans
2.3 Galaxo
2.3.1 Galaxo Details
2.3.2 Galaxo Major Business
2.3.3 Galaxo Intramuscular Drug Delivery Product and Solutions
2.3.4 Galaxo Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Galaxo Recent Developments and Future Plans
2.4 HMD pharmaceuticals
2.4.1 HMD pharmaceuticals Details
2.4.2 HMD pharmaceuticals Major Business
2.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Product and Solutions
2.4.4 HMD pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 HMD pharmaceuticals Recent Developments and Future Plans
2.5 Inovio Pharmaceuticals
2.5.1 Inovio Pharmaceuticals Details
2.5.2 Inovio Pharmaceuticals Major Business
2.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
2.5.4 Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Inovio Pharmaceuticals Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Intramuscular Drug Delivery Product and Solutions
2.6.4 Merck Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Merck Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Intramuscular Drug Delivery Product and Solutions
2.7.4 Novartis Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Pacira Pharmaceuticals
2.8.1 Pacira Pharmaceuticals Details
2.8.2 Pacira Pharmaceuticals Major Business
2.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
2.8.4 Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Pacira Pharmaceuticals Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Intramuscular Drug Delivery Product and Solutions
2.9.4 Pfizer Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Pharmajet
2.10.1 Pharmajet Details
2.10.2 Pharmajet Major Business
2.10.3 Pharmajet Intramuscular Drug Delivery Product and Solutions
2.10.4 Pharmajet Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pharmajet Recent Developments and Future Plans
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business
2.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Product and Solutions
2.11.4 Teva Pharmaceutical Intramuscular Drug Delivery Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Teva Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Intramuscular Drug Delivery Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Intramuscular Drug Delivery Players Market Share in 2021
3.2.2 Top 10 Intramuscular Drug Delivery Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Intramuscular Drug Delivery Players Head Office, Products and Services Provided
3.4 Intramuscular Drug Delivery Mergers & Acquisitions
3.5 Intramuscular Drug Delivery New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Intramuscular Drug Delivery Revenue and Market Share by Type (2017-2022)
4.2 Global Intramuscular Drug Delivery Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Intramuscular Drug Delivery Revenue Market Share by Application (2017-2022)
5.2 Global Intramuscular Drug Delivery Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Intramuscular Drug Delivery Revenue by Type (2017-2028)
6.2 North America Intramuscular Drug Delivery Revenue by Application (2017-2028)
6.3 North America Intramuscular Drug Delivery Market Size by Country
6.3.1 North America Intramuscular Drug Delivery Revenue by Country (2017-2028)
6.3.2 United States Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
6.3.3 Canada Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
6.3.4 Mexico Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Intramuscular Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Intramuscular Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Intramuscular Drug Delivery Market Size by Country
7.3.1 Europe Intramuscular Drug Delivery Revenue by Country (2017-2028)
7.3.2 Germany Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.3 France Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.5 Russia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
7.3.6 Italy Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Intramuscular Drug Delivery Revenue by Type (2017-2028)
8.2 Asia-Pacific Intramuscular Drug Delivery Revenue by Application (2017-2028)
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Intramuscular Drug Delivery Revenue by Region (2017-2028)
8.3.2 China Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.3 Japan Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.4 South Korea Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.5 India Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
8.3.7 Australia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Intramuscular Drug Delivery Revenue by Type (2017-2028)
9.2 South America Intramuscular Drug Delivery Revenue by Application (2017-2028)
9.3 South America Intramuscular Drug Delivery Market Size by Country
9.3.1 South America Intramuscular Drug Delivery Revenue by Country (2017-2028)
9.3.2 Brazil Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
9.3.3 Argentina Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Intramuscular Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East & Africa Intramuscular Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Intramuscular Drug Delivery Revenue by Country (2017-2028)
10.3.2 Turkey Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
10.3.4 UAE Intramuscular Drug Delivery Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Intramuscular Drug Delivery Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Intramuscular Drug Delivery Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Intramuscular Drug Delivery Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Intramuscular Drug Delivery Revenue (USD Million) by Region (2017-2022)
Table 5. Global Intramuscular Drug Delivery Revenue Market Share by Region (2023-2028)
Table 6. Antares Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Antares Pharma Major Business
Table 8. Antares Pharma Intramuscular Drug Delivery Product and Solutions
Table 9. Antares Pharma Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Eli Lily Corporate Information, Head Office, and Major Competitors
Table 11. Eli Lily Major Business
Table 12. Eli Lily Intramuscular Drug Delivery Product and Solutions
Table 13. Eli Lily Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Galaxo Corporate Information, Head Office, and Major Competitors
Table 15. Galaxo Major Business
Table 16. Galaxo Intramuscular Drug Delivery Product and Solutions
Table 17. Galaxo Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. HMD pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. HMD pharmaceuticals Major Business
Table 20. HMD pharmaceuticals Intramuscular Drug Delivery Product and Solutions
Table 21. HMD pharmaceuticals Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Inovio Pharmaceuticals Major Business
Table 24. Inovio Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
Table 25. Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck Intramuscular Drug Delivery Product and Solutions
Table 29. Merck Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Intramuscular Drug Delivery Product and Solutions
Table 33. Novartis Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pacira Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Pacira Pharmaceuticals Major Business
Table 36. Pacira Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
Table 37. Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Intramuscular Drug Delivery Product and Solutions
Table 41. Pfizer Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pharmajet Corporate Information, Head Office, and Major Competitors
Table 43. Pharmajet Major Business
Table 44. Pharmajet Intramuscular Drug Delivery Product and Solutions
Table 45. Pharmajet Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Teva Pharmaceutical Major Business
Table 48. Teva Pharmaceutical Intramuscular Drug Delivery Product and Solutions
Table 49. Teva Pharmaceutical Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Intramuscular Drug Delivery Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Intramuscular Drug Delivery Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Intramuscular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Intramuscular Drug Delivery Players Head Office, Products and Services Provided
Table 54. Intramuscular Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 55. Intramuscular Drug Delivery New Entrants and Expansion Plans
Table 56. Global Intramuscular Drug Delivery Revenue (USD Million) by Type (2017-2022)
Table 57. Global Intramuscular Drug Delivery Revenue Share by Type (2017-2022)
Table 58. Global Intramuscular Drug Delivery Revenue Forecast by Type (2023-2028)
Table 59. Global Intramuscular Drug Delivery Revenue by Application (2017-2022)
Table 60. Global Intramuscular Drug Delivery Revenue Forecast by Application (2023-2028)
Table 61. North America Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Intramuscular Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Intramuscular Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Intramuscular Drug Delivery Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Intramuscular Drug Delivery Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Intramuscular Drug Delivery Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Intramuscular Drug Delivery Revenue (USD Million) by Region (2017-2022)
Table 5. Global Intramuscular Drug Delivery Revenue Market Share by Region (2023-2028)
Table 6. Antares Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Antares Pharma Major Business
Table 8. Antares Pharma Intramuscular Drug Delivery Product and Solutions
Table 9. Antares Pharma Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Eli Lily Corporate Information, Head Office, and Major Competitors
Table 11. Eli Lily Major Business
Table 12. Eli Lily Intramuscular Drug Delivery Product and Solutions
Table 13. Eli Lily Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Galaxo Corporate Information, Head Office, and Major Competitors
Table 15. Galaxo Major Business
Table 16. Galaxo Intramuscular Drug Delivery Product and Solutions
Table 17. Galaxo Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. HMD pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. HMD pharmaceuticals Major Business
Table 20. HMD pharmaceuticals Intramuscular Drug Delivery Product and Solutions
Table 21. HMD pharmaceuticals Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Inovio Pharmaceuticals Major Business
Table 24. Inovio Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
Table 25. Inovio Pharmaceuticals Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck Intramuscular Drug Delivery Product and Solutions
Table 29. Merck Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Intramuscular Drug Delivery Product and Solutions
Table 33. Novartis Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Pacira Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Pacira Pharmaceuticals Major Business
Table 36. Pacira Pharmaceuticals Intramuscular Drug Delivery Product and Solutions
Table 37. Pacira Pharmaceuticals Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Intramuscular Drug Delivery Product and Solutions
Table 41. Pfizer Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pharmajet Corporate Information, Head Office, and Major Competitors
Table 43. Pharmajet Major Business
Table 44. Pharmajet Intramuscular Drug Delivery Product and Solutions
Table 45. Pharmajet Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Teva Pharmaceutical Major Business
Table 48. Teva Pharmaceutical Intramuscular Drug Delivery Product and Solutions
Table 49. Teva Pharmaceutical Intramuscular Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Intramuscular Drug Delivery Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Intramuscular Drug Delivery Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Intramuscular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Intramuscular Drug Delivery Players Head Office, Products and Services Provided
Table 54. Intramuscular Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 55. Intramuscular Drug Delivery New Entrants and Expansion Plans
Table 56. Global Intramuscular Drug Delivery Revenue (USD Million) by Type (2017-2022)
Table 57. Global Intramuscular Drug Delivery Revenue Share by Type (2017-2022)
Table 58. Global Intramuscular Drug Delivery Revenue Forecast by Type (2023-2028)
Table 59. Global Intramuscular Drug Delivery Revenue by Application (2017-2022)
Table 60. Global Intramuscular Drug Delivery Revenue Forecast by Application (2023-2028)
Table 61. North America Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Intramuscular Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Intramuscular Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Intramuscular Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Intramuscular Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Intramuscular Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Intramuscular Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Intramuscular Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Intramuscular Drug Delivery Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Intramuscular Drug Delivery Picture
Figure 2. Global Intramuscular Drug Delivery Revenue Market Share by Type in 2021
Figure 3. Drug Molecule
Figure 4. Delivery Devices
Figure 5. Intramuscular Drug Delivery Revenue Market Share by Application in 2021
Figure 6. Infectious Disease Picture
Figure 7. Oncology Picture
Figure 8. Autoimmune Diseases Picture
Figure 9. Global Intramuscular Drug Delivery Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Intramuscular Drug Delivery Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intramuscular Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 12. Global Intramuscular Drug Delivery Revenue Market Share by Region in 2021
Figure 13. North America Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Intramuscular Drug Delivery Market Drivers
Figure 19. Intramuscular Drug Delivery Market Restraints
Figure 20. Intramuscular Drug Delivery Market Trends
Figure 21. Antares Pharma Recent Developments and Future Plans
Figure 22. Eli Lily Recent Developments and Future Plans
Figure 23. Galaxo Recent Developments and Future Plans
Figure 24. HMD pharmaceuticals Recent Developments and Future Plans
Figure 25. Inovio Pharmaceuticals Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Pacira Pharmaceuticals Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Pharmajet Recent Developments and Future Plans
Figure 31. Teva Pharmaceutical Recent Developments and Future Plans
Figure 32. Global Intramuscular Drug Delivery Revenue Share by Players in 2021
Figure 33. Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Intramuscular Drug Delivery Revenue Market Share in 2021
Figure 35. Global Top 10 Players Intramuscular Drug Delivery Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Intramuscular Drug Delivery Revenue Share by Type in 2021
Figure 38. Global Intramuscular Drug Delivery Market Share Forecast by Type (2023-2028)
Figure 39. Global Intramuscular Drug Delivery Revenue Share by Application in 2021
Figure 40. Global Intramuscular Drug Delivery Market Share Forecast by Application (2023-2028)
Figure 41. North America Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 42. North America Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 43. North America Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 44. United States Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 48. Europe Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 49. Europe Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 50. Germany Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Intramuscular Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 58. China Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 65. South America Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 66. South America Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Intramuscular Drug Delivery Picture
Figure 2. Global Intramuscular Drug Delivery Revenue Market Share by Type in 2021
Figure 3. Drug Molecule
Figure 4. Delivery Devices
Figure 5. Intramuscular Drug Delivery Revenue Market Share by Application in 2021
Figure 6. Infectious Disease Picture
Figure 7. Oncology Picture
Figure 8. Autoimmune Diseases Picture
Figure 9. Global Intramuscular Drug Delivery Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Intramuscular Drug Delivery Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intramuscular Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 12. Global Intramuscular Drug Delivery Revenue Market Share by Region in 2021
Figure 13. North America Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Intramuscular Drug Delivery Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Intramuscular Drug Delivery Market Drivers
Figure 19. Intramuscular Drug Delivery Market Restraints
Figure 20. Intramuscular Drug Delivery Market Trends
Figure 21. Antares Pharma Recent Developments and Future Plans
Figure 22. Eli Lily Recent Developments and Future Plans
Figure 23. Galaxo Recent Developments and Future Plans
Figure 24. HMD pharmaceuticals Recent Developments and Future Plans
Figure 25. Inovio Pharmaceuticals Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Pacira Pharmaceuticals Recent Developments and Future Plans
Figure 29. Pfizer Recent Developments and Future Plans
Figure 30. Pharmajet Recent Developments and Future Plans
Figure 31. Teva Pharmaceutical Recent Developments and Future Plans
Figure 32. Global Intramuscular Drug Delivery Revenue Share by Players in 2021
Figure 33. Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Intramuscular Drug Delivery Revenue Market Share in 2021
Figure 35. Global Top 10 Players Intramuscular Drug Delivery Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Intramuscular Drug Delivery Revenue Share by Type in 2021
Figure 38. Global Intramuscular Drug Delivery Market Share Forecast by Type (2023-2028)
Figure 39. Global Intramuscular Drug Delivery Revenue Share by Application in 2021
Figure 40. Global Intramuscular Drug Delivery Market Share Forecast by Application (2023-2028)
Figure 41. North America Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 42. North America Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 43. North America Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 44. United States Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 48. Europe Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 49. Europe Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 50. Germany Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Intramuscular Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 58. China Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 65. South America Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 66. South America Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Intramuscular Drug Delivery Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Intramuscular Drug Delivery Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Intramuscular Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Intramuscular Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
